Peter Horak
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer
- Cell death mechanisms and regulation
- Epigenetics and DNA Methylation
- RNA modifications and cancer
Papers in
-
- Cancer Genomics and Diagnostics 21
- Oncology 24
- Cancer Immunotherapy and Biomarkers 8
- Co-authors
- Leif W. EllisenDennis C. SgroiM. Phillip DeYoungMichael KrainerDietmar PilsStefan FröhlingHanno GlimmRobert Zeillinger
In The Last Decade
Peter Horak
61 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 590
- Molecular Biology 1.2k
- Oncology 457
- Cell Biology 188
- Immunology 235
Countries citing papers authored by Peter Horak
This map shows the geographic impact of Peter Horak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Horak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Horak more than expected).
Fields of papers citing papers by Peter Horak
This network shows the impact of papers produced by Peter Horak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Horak. The network helps show where Peter Horak may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Horak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 7 | |
| 5 | 2021 | 3 | |
| 6 | 2020 | 17 | |
| 7 | APPLICATION OF “CODEVE” METHODOLOGY IN TRANSATLANTIC STUDENT DESIGN PROJECT | 2018 | 0 |
| 8 | 2017 | 20 | |
| 9 | 2017 | 3 | |
| 10 | 2014 | 72 | |
| 11 | 2014 | 47 | |
| 12 | 2014 | 2 | |
| 13 | 2012 | 18 | |
| 14 | 2011 | 37 | |
| 15 | N33 (TUSC3) promoter hypermethylation in serum of prostate cancer patients | 2006 | 2 |
| 16 | Hypermethylation of N33 (TUSC3) as independent molecular predictor for ovarian cancer | 2006 | 2 |
| 17 | 2006 | 62 | |
| 18 | 2005 | 18 | |
| 19 | 2005 | 77 | |
| 20 | 2004 | 50 |
About Peter Horak
Peter Horak is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Reproductive Medicine and Molecular Biology, having authored 68 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (21 papers), Lung Cancer Treatments and Mutations (8 papers), Epigenetics and DNA Methylation (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cell death mechanisms and regulation (7 papers), Sarcoma Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Cancer Research (590 citations), Molecular Biology (1.2k citations), Oncology (457 citations), Cell Biology (188 citations) and Immunology (235 citations). Peter Horak has collaborated with scholars based in Germany, Austria and Czechia. Frequent co-authors include Leif W. Ellisen, Dennis C. Sgroi, M. Phillip DeYoung, Michael Krainer, Dietmar Pils, Stefan Fröhling, Hanno Glimm, Robert Zeillinger, Reinhard Horvat and Christoph Zielinski. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.